A series of novel bis(β-cyclodextrin)s connected by organoselenium linkers, i.e., 6,6‘-trimethylenediseleno-bridged bis(β-cyclodextrin) (2), 2,2‘-trimethylenediseleno-bridged bis(β-cyclodextrin) (3),
6,6‘-o-phenylenediseleno-bridged bis(β-cyclodextrin) (4), and the corresponding platinum(IV)
complexes (5−7) were synthesized from β-cyclodextrin (1). The inclusion complexation behavior of
1−7 with some fluorescent dyes, i.e., ammonium 8-anilino-1-naphthalenesulfonate, sodium 2-(p-toluidinyl)naphthalenesulfonate, Methyl Orange, and Mordant Orange 1, was investigated in
aqueous phosphate buffer solution (pH 7.20) at 25 °C by fluorescence and circular dichroism
spectrometry, as well as fluorescence lifetime measurements. The spectrofluorometric and spectropolarimetric titrations gave the complex stability constant (K
S) and Gibbs free energy change
(ΔG°) for the stoichiometric 1:1 inclusion complexation of 1−7 with the fluorescent dyes. The bis(β-cyclodextrin)s 2−4 showed higher affinities toward these guests than native β-cyclodextrin, and
the binding abilities of 5−7 were further enhanced by incorporating Pt(IV). The cooperative binding
abilities of these bis(β-cyclodextrin)s are discussed from the viewpoints of the size/shape-fit concept,
the induced-fit interaction, and the multiple recognition mechanism.
A single crystal of mono(6-anilino-6-deoxy)-beta-cyclodextrin was prepared, and its crystal structure was determined by X-ray crystallographic analysis, which clearly revealed that the anilino groups are consecutively included intermolecularly into the adjacent cyclodextrin cavities in the crystal, thus giving rise to a consolidated column, located on a 2(1)-screw axis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.